Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with suspected ovarian, fallopian tube, or primary peritoneal cancer that is at an advanced stage (classified as FIGO stage IIIA or higher)
- People aged between 18 and 80 years old
- People whose doctors estimate they have a life expectancy of at least 4 weeks
- People who have signed a form confirming they understand and agree to take part in the trial
Who may not be able to join:
- People who have had any other type of cancer within the last 5 years
- People who have previously received chemotherapy or targeted cancer treatments
- People who have been diagnosed with two separate, unrelated cancers occurring at the same time
- People who are currently pregnant or breastfeeding
- People who have not signed the required consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Camilla Nero, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: 0630158667
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the ability of ctDNA to detect Ovarian Cancer recurrence. predictive value (NPV)).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.